FDA Inspection 1201162 — Beximco Pharmaceuticals Limited
The FDA completed an inspection of Beximco Pharmaceuticals Limited on March 30, 2023 in Gazipur. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 30, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gazipur (Bangladesh)
Citations
| ID | CFR | Description |
|---|---|---|
| 4342 | 21 CFR 211.142(b) | Storage under appropriate conditions |